Mechanisms leading to secondary resistance to L-asparaginase treatment remains to be uncovered. Here, the authors show that L-asparaginase rewires B-cell lymphomas metabolism, creating a targetable vulnerability to the PARP1/2 inhibitor Olaparib.
- Anaïs Aussel
- Ivan Nemazanyy
- Johanna Chiche
